madman
Super Moderator
*the secret sauce is really the medication, it's the drug coating of paclitaxel that gets eluded into the freshly opened up scar tissue absorbed and it prevents healing
*antiproliferative property of paclitaxel that prevents scarring from coming down
Dean Elterman, MD is discussing Optilume, a New Treatment Option for BPH. Optilume is positioned within the prostatic urethra, which is the part of the urethra that runs through the prostate gland. The balloon is then inflated to open up the narrowed or obstructed area and deliver the medication to the surrounding tissues. The medication helps to reduce the size of the prostate gland and alleviate the symptoms of BPH.
Optilume aims to provide relief from urinary symptoms caused by BPH while minimizing the risks and side effects associated with more invasive surgical treatments. However, it's important to note that medical procedures and devices can evolve over time, so it's always recommended to consult with a qualified healthcare professional for the most up-to-date and accurate information about specific treatments and technologies.
*antiproliferative property of paclitaxel that prevents scarring from coming down
Dean Elterman, MD is discussing Optilume, a New Treatment Option for BPH. Optilume is positioned within the prostatic urethra, which is the part of the urethra that runs through the prostate gland. The balloon is then inflated to open up the narrowed or obstructed area and deliver the medication to the surrounding tissues. The medication helps to reduce the size of the prostate gland and alleviate the symptoms of BPH.
Optilume aims to provide relief from urinary symptoms caused by BPH while minimizing the risks and side effects associated with more invasive surgical treatments. However, it's important to note that medical procedures and devices can evolve over time, so it's always recommended to consult with a qualified healthcare professional for the most up-to-date and accurate information about specific treatments and technologies.
